Amylgen is a contract research organization that offers in vivo models of ageing, psychiatric, and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Its technical platform provides a service helping to characterize the experiment with behavioral, biochemical, histological, and pharmacokinetic data.